The Recall Desk
SevereFDA (Drugs)·D-1363-2020·Announced 2020-07-08

MasterPharm Recalls Compounded Minoxidil, Biotin, and Spironolactone Capsules

MasterPharm LLC is recalling compounded Minoxidil/Biotin/Spironolactone capsules due to elevated levels of minoxidil and biotin. The product was distributed in Florida and Maryland.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.

Plain-English summary

MasterPharm LLC is recalling a specific lot of compounded Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsules. The recall was initiated because the product contains elevated levels of minoxidil and biotin, making it a super-potent drug.

The affected product consists of 90-capsule bottles, with a total of 300 capsules involved in the recall. The specific lot number is 01-09-2020:13@8, and the expiration date is July 7, 2020. The product was distributed in Florida and Maryland.

Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions. The product is a compounded drug not intended for resale.

The recalled product

Product
Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room temperature, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
Manufacturer
MasterPharm LLC
Category
Drug — Compounded Prescription
Hazard
Affected units
300

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 01-09-2020:13@8
  • Exp. 7/7/2020

Distribution

Distributed in 2 states:

Related recalls

Same manufacturer · MasterPharm LLC

See all →